EMA/PE/0000226088 - paediatric investigation plan

relacorilant

Key facts

• Active substance:
  relacorilant
• Therapeutic area:
  Surgical and medical procedures
• Decision number:
  EMA/PE/0000226088
• PIP number:
  EMA/PE/0000226088
• Pharmaceutical form(s):
  Capsule, soft
• Condition(s) / indication(s):
  • Ovarian cancer epithelial ovarian
  • Treatment of fallopian tube cancer
  • Treatment of primary peritoneal cancer
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  28/01/2025
• Compliance check done:
  No

Decision

EMA/PE/0000226088 : of 28 January 2025 on the granting of a product specific waiver for relacorilant

Adopted